An experimental vaccine that could protect millions of people living in the American Southwest from valley fever has passed its first test of efficacy and is moving toward federal approval, possibly within two years. The vaccine candidate, was developed by the Valley Fever Center for Excellence at the University of Arizona College of Medicine – Tucson, was tested in, and will be developed for, dogs.

Researchers targeted a common sodium ion channel to reverse pain and saw positive results that could lead to a non-addictive solution to treat pain.

Thank you to the Health Sciences veterans who submitted photos for our Veterans Day gallery, and thanks to all our veterans for serving our country.

A University of Arizona Health Sciences-led study uncovered disparities in breast cancer treatments that may lead to poorer health outcomes in Indigenous women, who currently have the worst breast cancer survival outcomes of any racial group in the U.S.

Researchers at the University of Arizona Health Sciences are closer to developing a safe and effective non-opioid pain reliever after a study showed that a new compound they created reduces the sensation of pain by regulating a biological channel linked to pain.

A recent COVID-19 interprofessional education exercise put lessons learned at the forefront and fostered collaboration for Health Sciences students.

Native and Indigenous women had a higher percentage of mastectomy and a lower percentage of lumpectomy compared with white women.

A $50 million gift establishes six new endowed chairs, four new endowed professorships, 42 new endowed scholarships and equipment and facility upgrades.